Happy Sunday and welcome to InsideAI! I'm Rob May, a Partner at PJC, focused on AI and Robotics. This Sunday edition is a summary of things I'm seeing in the AI space. Today's commentary is on the risk of misunderstanding tech, and what happens if we build on that misunderstanding.
Also check out this week's edition of the Investing in AI podcast with NY Times tech reporter Kevin Roose. Kevin recently published the book Futureproof: 9 Rules For Humans In The Age of Automation. We talk about AI, the RPA industry, and how to make sure your job doesn't get automated away.
Let's revisit the most popular articles of the past week:
Citing national security concerns, the U.S. has added seven Chinese supercomputer building companies/branches to the sanction list. Now they are required to obtain a license from the Commerce Department to trade with U.S. companies. The Commerce Department says it blacklisted the entities for building supercomputers that are used by China’s "military actors, its destabilizing military modernization efforts, and/or weapons of mass destruction programs." Reports noted that China is utilizing supercomputers to accelerate the development of hypersonic missiles, which could reach velocities of at least 5x the speed of sound and are virtually unstoppable.
An anonymous source provided BuzzFeed News with a list of companies and government agencies whose employees have tried Clearview AI's facial recognition tool. Employees from at least 1,803 agencies used the software starting in 2018 through February 2020, the data shows. Many of those employees never gained approval from higher-ups to try out the technology.
Health care and industrial AI companies dominated CB Insights' latest annual AI 100. For the fifth year, the research firm ranked among the most promising private firms working in the AI space. This year's list includes 100 private market vendors from a pool of 6K+ companies. The winners are based in 12 countries and work in 18 different industries. 64% are headquartered in the U.S., followed by 8% in the U.K., and 6% each in Israel and China.